undamentalytics Newsletter

Electromed, Inc. cash flow statement

In fiscal 2026, Electromed, Inc.'s operations generated $9.7m of cash; it spent $1.3m on capital projects, leaving free cash flow of $8.4m. It returned $3.9m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Electromed, Inc.: cash flow statement, annual
Fiscal year2011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026
Cash from operations−1−1223212343−1191110
Depreciation and amortisation0001111111011111
Stock-based pay0000000111111233
Capital spending0111111111012001
Free cash flow−2−2112212133−2−09118
Free cash flow after stock pay−2−2112101022−3−1786
Share buybacks——————————1100104
Shares issued6———————————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ELMD vs RCELELMD vs PDEXELMD vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Electromed, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Electromed, Inc.